Following The Money: Institution’s Growing Stake In Nuwellis Inc (NASDAQ: NUWE)

Nuwellis Inc (NUWE) concluded trading on Wednesday at a closing price of $0.37, with 434.65 million shares of worth about $160.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -70.94% during that period and on June 11, 2025 the price saw a gain of about 57.56%. Currently the company’s common shares owned by public are about 4.37M shares, out of which, 4.37M shares are available for trading.

Stock saw a price change of -52.09% in past 5 days and over the past one month there was a price change of -62.73%. Year-to-date (YTD), NUWE shares are showing a performance of -66.76% which decreased to -95.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.21 but also hit the highest price of $8.23 during that period. The average intraday trading volume for Nuwellis Inc shares is 1.64 million. The stock is currently trading -51.94% below its 20-day simple moving average (SMA20), while that difference is down -57.53% for SMA50 and it goes to -69.51% lower than SMA200.

Nuwellis Inc (NASDAQ: NUWE) currently have 4.37M outstanding shares and institutions hold larger chunk of about 3.16% of that.

The stock has a current market capitalization of $1.76M and its 3Y-monthly beta is at 0.42. It has posted earnings per share of -$18.24 in the same period. It has Quick Ratio of 1.59 while making debt-to-equity ratio of 0.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NUWE, volatility over the week remained 45.92% while standing at 19.50% over the month.

Stock’s fiscal year EPS is expected to rise by 77.05% while it is estimated to increase by 52.33% in next year. EPS is likely to shrink at an annualized rate of 83.18% for next 5-years, compared to annual growth of 90.39% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by ROTH MKM on July 29, 2024 offering a Buy rating for the stock and assigned a target price of $17 to it.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.